ARROWHEAD PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Diluted Shares Outstanding (Weighted Average) of 143.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 143.38M shares, a 3.12% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 142.42M shares, a 5.90% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 140.71M shares, a 12.70% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 134.98M shares, a 8.54% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 133.76M shares, a 11.67% increase from fiscal 2024.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 119.78M shares, a 12.21% increase from fiscal 2023.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 106.75M shares, a 1.26% increase from fiscal 2022.
- ARROWHEAD PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 105.43M shares, a 1.62% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 143.38M shares 10-Q · filed 2026-08-04 | 142.90M shares derived: average of 2 quarters · filed 2026-08-04 | 141.33M shares 10-Q · filed 2026-08-04 | 140.37M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | 142.42M shares 10-Q · filed 2026-05-07 | 139.76M shares 10-Q · filed 2026-05-07 | 139.37M shares derived: average of 3 quarters · filed 2026-05-07 | 139.28M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | 140.71M shares 10-Q · filed 2026-02-05 | 137.84M shares derived: average of 2 quarters · filed 2026-02-05 | 138.24M shares derived: average of 3 quarters · filed 2026-08-04 | 137.30M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-09-30 | 134.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 137.01M shares derived: average of 2 quarters · filed 2026-08-04 | 136.17M shares derived: average of 3 quarters · filed 2026-08-04 | 133.76M shares 10-K · filed 2025-11-25 | ||||
| 2025-06-30 | 139.04M shares 10-Q · filed 2026-08-04 | 136.76M shares derived: average of 2 quarters · filed 2026-08-04 | 133.35M shares 10-Q · filed 2026-08-04 | 130.68M shares derived: average of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | 134.48M shares 10-Q · filed 2026-05-07 | 130.26M shares 10-Q · filed 2026-05-07 | 127.90M shares derived: average of 3 quarters · filed 2026-05-07 | 126.97M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 124.85M shares 10-Q · filed 2026-02-05 | 124.60M shares derived: average of 2 quarters · filed 2026-02-05 | 124.47M shares derived: average of 3 quarters · filed 2026-02-05 | 124.17M shares derived: average of 4 quarters · filed 2026-02-05 | ||||
| 2024-09-30 | 124.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 124.28M shares derived: average of 2 quarters · filed 2025-11-25 | 123.95M shares derived: average of 3 quarters · filed 2025-11-25 | 119.78M shares 10-K · filed 2025-11-25 | ||||
| 2024-06-30 | 124.20M shares 10-Q · filed 2025-08-07 | 123.74M shares derived: average of 2 quarters · filed 2025-08-07 | 118.26M shares 10-Q · filed 2025-08-07 | 115.53M shares derived: average of 4 quarters · filed 2025-11-25 | ||||
| 2024-03-31 | 123.28M shares 10-Q · filed 2025-05-12 | 115.31M shares 10-Q · filed 2025-05-12 | 112.64M shares derived: average of 3 quarters · filed 2025-11-25 | 111.23M shares derived: average of 4 quarters · filed 2025-11-25 | ||||
| 2023-12-31 | 107.42M shares 10-Q · filed 2025-02-10 | 107.31M shares derived: average of 2 quarters · filed 2025-11-25 | 107.21M shares derived: average of 3 quarters · filed 2025-11-25 | 107.44M shares derived: average of 4 quarters · filed 2025-11-25 | ||||
| 2023-09-30 | 107.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | 107.11M shares derived: average of 2 quarters · filed 2025-11-25 | 107.45M shares derived: average of 3 quarters · filed 2025-11-25 | 106.75M shares 10-K · filed 2025-11-25 | ||||
| 2023-06-30 | 107.00M shares 10-Q · filed 2024-08-08 | 107.57M shares derived: average of 2 quarters · filed 2024-08-08 | 106.60M shares 10-Q · filed 2024-08-08 | 106.77M shares derived: average of 4 quarters · filed 2024-11-26 | ||||
| 2023-03-31 | 108.14M shares 10-Q · filed 2024-05-09 | 107.89M shares 10-Q · filed 2024-05-09 | 106.69M shares derived: average of 3 quarters · filed 2024-11-26 | 106.45M shares derived: average of 4 quarters · filed 2024-11-26 | ||||
| 2022-12-31 | 106.04M shares 10-Q · filed 2024-02-06 | 105.96M shares derived: average of 2 quarters · filed 2024-11-26 | 105.89M shares derived: average of 3 quarters · filed 2024-11-26 | 106.40M shares derived: average of 4 quarters · filed 2024-11-26 | ||||
| 2022-09-30 | 105.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | 105.82M shares derived: average of 2 quarters · filed 2024-11-26 | 106.52M shares derived: average of 3 quarters · filed 2024-11-26 | 105.43M shares 10-K · filed 2024-11-26 | ||||
| 2022-06-30 | 105.75M shares 10-Q · filed 2023-08-07 | 106.84M shares derived: average of 2 quarters · filed 2023-08-07 | 105.27M shares 10-Q · filed 2023-08-07 | 105.62M shares derived: average of 4 quarters · filed 2023-11-29 | ||||
| 2022-03-31 | 107.93M shares 10-Q · filed 2023-05-02 | 105.03M shares 10-Q · filed 2023-05-02 | 105.58M shares derived: average of 3 quarters · filed 2023-11-29 | 105.21M shares derived: average of 4 quarters · filed 2023-11-29 | ||||
| 2021-12-31 | 104.53M shares 10-Q · filed 2023-02-06 | 104.40M shares derived: average of 2 quarters · filed 2023-11-29 | 104.30M shares derived: average of 3 quarters · filed 2023-11-29 | 104.19M shares derived: average of 4 quarters · filed 2023-11-29 | ||||
| 2021-09-30 | 104.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | 104.19M shares derived: average of 2 quarters · filed 2023-11-29 | 104.08M shares derived: average of 3 quarters · filed 2023-11-29 | 103.75M shares 10-K · filed 2023-11-29 | ||||
| 2021-06-30 | 104.10M shares 10-Q · filed 2022-08-04 | 103.98M shares derived: average of 2 quarters · filed 2022-08-04 | 103.57M shares 10-Q · filed 2022-08-04 | 103.26M shares derived: average of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | 103.87M shares 10-Q · filed 2022-05-10 | 103.30M shares 10-Q · filed 2022-05-10 | 102.99M shares derived: average of 3 quarters · filed 2022-11-28 | 102.70M shares derived: average of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | 102.76M shares 10-Q · filed 2022-02-02 | 102.55M shares derived: average of 2 quarters · filed 2022-11-28 | 102.31M shares derived: average of 3 quarters · filed 2022-11-28 | 102.15M shares derived: average of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | 102.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | 102.09M shares derived: average of 2 quarters · filed 2022-11-28 | 101.94M shares derived: average of 3 quarters · filed 2022-11-28 | 100.72M shares 10-K · filed 2022-11-28 | 100.72M shares 10-K · filed 2020-11-23 | |||
| 2020-06-30 | 101.84M shares 10-Q · filed 2021-08-05 | 101.84M shares 10-Q · filed 2020-08-05 | 101.75M shares derived: average of 2 quarters · filed 2021-08-05 | 100.18M shares 10-Q · filed 2021-08-05 | 100.18M shares 10-Q · filed 2020-08-05 | 100.39M shares derived: average of 4 quarters · filed 2021-11-22 | ||
| 2020-03-31 | 101.65M shares 10-Q · filed 2021-05-04 | 101.65M shares 10-Q · filed 2020-05-07 | 99.36M shares 10-Q · filed 2021-05-04 | 99.36M shares 10-Q · filed 2020-05-07 | 99.91M shares derived: average of 3 quarters · filed 2021-11-22 | 99.65M shares derived: average of 4 quarters · filed 2021-11-22 | ||
| 2019-12-31 | 97.09M shares 10-Q · filed 2021-02-04 | 97.09M shares 10-Q · filed 2020-02-05 | 99.04M shares derived: average of 2 quarters · filed 2021-11-22 | 98.99M shares derived: average of 3 quarters · filed 2021-11-22 | 98.76M shares derived: average of 4 quarters · filed 2021-11-22 | |||
| 2019-09-30 | 100.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | 99.94M shares derived: average of 2 quarters · filed 2021-11-22 | 99.32M shares derived: average of 3 quarters · filed 2021-11-22 | 98.61M shares 10-K · filed 2021-11-22 | 98.61M shares 10-K · filed 2019-11-25 | |||
| 2019-06-30 | 98.88M shares 10-Q · filed 2020-08-05 | 98.48M shares derived: average of 2 quarters · filed 2020-08-05 | 97.81M shares 10-Q · filed 2020-08-05 | 95.17M shares derived: average of 4 quarters · filed 2020-11-23 | ||||
| 2019-03-31 | 98.08M shares 10-Q · filed 2020-05-07 | 97.21M shares 10-Q · filed 2020-05-07 | 93.93M shares derived: average of 3 quarters · filed 2020-11-23 | 92.35M shares derived: average of 4 quarters · filed 2020-11-23 | ||||
| 2018-12-31 | 95.59M shares 10-Q · filed 2020-02-05 | 91.85M shares derived: average of 2 quarters · filed 2020-11-23 | 90.44M shares derived: average of 3 quarters · filed 2020-11-23 | 88.85M shares derived: average of 4 quarters · filed 2020-11-23 | ||||
| 2018-09-30 | 88.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | 87.87M shares derived: average of 2 quarters · filed 2020-11-23 | 86.61M shares derived: average of 3 quarters · filed 2020-11-23 | 83.64M shares 10-K · filed 2020-11-23 | ||||
| 2018-06-30 | 87.63M shares 10-Q · filed 2019-08-05 | 85.86M shares derived: average of 2 quarters · filed 2019-08-05 | 82.15M shares 10-Q · filed 2019-08-05 | |||||
| 2018-03-31 | 84.08M shares 10-Q · filed 2019-05-08 | 79.41M shares 10-Q · filed 2019-05-08 | ||||||
| 2017-12-31 | 74.83M shares 10-Q · filed 2019-02-07 | |||||||
| 2017-09-30 | 73.90M shares 10-K · filed 2019-11-25 | |||||||
| 2012-06-30 | 11.24M shares 10-Q · filed 2012-08-13 | 10.95M shares derived: average of 2 quarters · filed 2012-08-13 | 10.67M shares 10-Q · filed 2012-08-13 | |||||
| 2012-03-31 | 10.66M shares 10-Q · filed 2012-05-08 | 10.39M shares 10-Q · filed 2012-05-08 | ||||||
| 2011-09-30 | 7.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | 7.47M shares derived: average of 2 quarters · filed 2012-08-13 | 7.61M shares derived: average of 3 quarters · filed 2012-08-13 | 7.83M shares 10-K · filed 2011-12-20 | ||||
| 2011-06-30 | 7.18M shares 10-Q · filed 2012-08-13 | 71.83M shares 10-Q · filed 2011-08-08 | 7.54M shares derived: average of 2 quarters · filed 2012-08-13 | 7.86M shares 10-Q · filed 2012-08-13 | 78.57M shares 10-Q · filed 2011-08-08 | |||
| 2011-03-31 | 7.89M shares 10-Q · filed 2012-05-08 | 7.99M shares 10-Q · filed 2012-05-08 | ||||||
| 2010-09-30 | -160.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-20 | -47.93M shares derived: average of 2 quarters · filed 2011-12-20 | 6.43M shares 10-K · filed 2011-12-20 | |||||
| 2010-06-30 | 64.58M shares 10-Q · filed 2011-08-08 | 62.06M shares 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |